These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 11877261)
1. Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy? Cooper N; Woloski BM; Fodero EM; Novoa M; Leber M; Beer JH; Bussel JB Blood; 2002 Mar; 99(6):1922-7. PubMed ID: 11877261 [TBL] [Abstract][Full Text] [Related]
2. Predicting response to splenectomy in children with immune thrombocytopenic purpura. Wood JH; Partrick DA; Hays T; Ziegler MM J Pediatr Surg; 2010 Jan; 45(1):140-4; discussion 144. PubMed ID: 20105594 [TBL] [Abstract][Full Text] [Related]
3. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Blanchette V; Imbach P; Andrew M; Adams M; McMillan J; Wang E; Milner R; Ali K; Barnard D; Bernstein M Lancet; 1994 Sep; 344(8924):703-7. PubMed ID: 7915773 [TBL] [Abstract][Full Text] [Related]
4. Use of anti-D in immune thrombocytopenic purpura as a means to prevent splenectomy: case reports from two University Hospital Medical Centers. Waintraub SE; Brody JI Semin Hematol; 2000 Jan; 37(1 Suppl 1):45-9. PubMed ID: 10676925 [TBL] [Abstract][Full Text] [Related]
5. Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin. Bussel JB; Pham LC; Aledort L; Nachman R Blood; 1988 Jul; 72(1):121-7. PubMed ID: 3134063 [TBL] [Abstract][Full Text] [Related]
6. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect. Bussel JB; Graziano JN; Kimberly RP; Pahwa S; Aledort LM Blood; 1991 May; 77(9):1884-93. PubMed ID: 1850307 [TBL] [Abstract][Full Text] [Related]
7. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat. Rodeghiero F Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569 [TBL] [Abstract][Full Text] [Related]
8. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura]. Vizcaíno G; Diez-Ewald M; Arteaga-Vizcaíno M; Torres E Invest Clin; 1992; 33(4):165-74. PubMed ID: 1338940 [TBL] [Abstract][Full Text] [Related]
9. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. Andrew M; Blanchette VS; Adams M; Ali K; Barnard D; Chan KW; DeVeber LB; Esseltine D; Israels S; Korbrinsky N J Pediatr; 1992 Apr; 120(4 Pt 1):522-7. PubMed ID: 1313096 [TBL] [Abstract][Full Text] [Related]
10. Clinical experience with anti-D in the treatment of idiopathic thrombocytopenic purpura. Scaradavou A; Bussel JB Semin Hematol; 1998 Jan; 35(1 Suppl 1):52-7. PubMed ID: 9523749 [TBL] [Abstract][Full Text] [Related]
11. [Late results of splenectomy in patients with chronic immune thrombocytopenic purpura]. Elezović I; Bosković D; Colović M; Tomin D; Suvajdzić N; Gotić M; Colović R; Popović M Acta Chir Iugosl; 2002; 49(3):29-34. PubMed ID: 12587445 [TBL] [Abstract][Full Text] [Related]
12. Splenectomy-sparing, long-term maintenance with anti-D for chronic immune (idiopathic) thrombocytopenic purpura: the New York Hospital experience. Scaradavou A Semin Hematol; 2000 Jan; 37(1 Suppl 1):42-4. PubMed ID: 10676924 [TBL] [Abstract][Full Text] [Related]
13. Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy. Michel M; Novoa MV; Bussel JB Br J Haematol; 2003 Oct; 123(1):142-6. PubMed ID: 14510957 [TBL] [Abstract][Full Text] [Related]
14. Use of intravenous anti-D in patients with refractory and relapsed immune thrombocytopenic purpura. Sajid R; Adil SN; Fadoo Z; Sabir S; Khurshid M J Pak Med Assoc; 2003 Nov; 53(11):537-9. PubMed ID: 14738260 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of anti-D for immune thrombocytopenic purpura in children. Naithani R; Kumar R; Mahapatra M; Tyagi S; Mishra P Indian Pediatr; 2010 Jun; 47(6):517-9. PubMed ID: 20019392 [TBL] [Abstract][Full Text] [Related]
16. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura. Shahgholi E; Vosough P; Sotoudeh K; Arjomandi K; Ansari S; Salehi S; Faranoush M; Ehsani MA Indian J Pediatr; 2008 Dec; 75(12):1231-5. PubMed ID: 19190878 [TBL] [Abstract][Full Text] [Related]
17. Fc receptor blockade in patients with refractory chronic immune thrombocytopenic purpura with anti-D IgG. Ambriz-Fernández R; Martínez-Murillo C; Quintana-González S; Collazo-Jaloma J; Bautista-Juárez J Arch Med Res; 2002; 33(6):536-40. PubMed ID: 12505098 [TBL] [Abstract][Full Text] [Related]
18. Initial management of immune thrombocytopenic purpura in adults: a randomized controlled trial comparing intermittent anti-D with routine care. George JN; Raskob GE; Vesely SK; Moore D; Lyons RM; Cobos E; Towell BL; Klug P; Guthrie TH Am J Hematol; 2003 Nov; 74(3):161-9. PubMed ID: 14587042 [TBL] [Abstract][Full Text] [Related]
19. Intravenous gammaglobulin (Gaminume) for treatment of chronic idiopathic thrombocytopenic purpura (ITP): a two-year follow-up. Warrier IA; Lusher JM Am J Hematol; 1986 Dec; 23(4):323-8. PubMed ID: 2431617 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura. Ramadan KM; El-Agnaf M Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]